Assignment: Assessing and Treating Patient With Bipolar Disorder
The patient is 26 yr. An old female of Korean descent came to her first appointment
following 21 days of hospitalization for acute mania onset. The patie
...
Assignment: Assessing and Treating Patient With Bipolar Disorder
The patient is 26 yr. An old female of Korean descent came to her first appointment
following 21 days of hospitalization for acute mania onset. The patient is alert, oriented with
impaired insight. The patient denies any suicidal and homicidal ideation. The patient denies any
delusional and paranoid thinking. The patient mood is happy and euthymic. Patient judgment is
intact. Speech is rapid, pressured, tangential. Affect Board. The patient is dressed in an evening
gown for her appointment. The patient is hyperactive and energetic. The patient has noted with
flights of the idea. The patient slept 5 hours last night. The patient is physically healthy, and lab
studies are within the normal range. Genetic testing comes back positive for the CYP2D6*10
allele. The patient is non-compliant with medication. The patient stopped taking her lithium since
she was discharged from the inpatient hospital. The young mania rating scale score is 22.
Introduction
Bipolar disorder is a recurrent and chronic disorder characterized by fluctuation in mood
and energy(Bonnin et al., 2019). People with bipolar frequently experience persistent residual
symptoms. The patient with bipolar disorder has problems in psychosocial functioning, cognitive
impairment, and poor quality of life(Bonnin et al., 2019). Patient with bipolar disorder exhibit
symptoms of mania with extremely elevated mood, energy, unusual thought pattern and
sometimes psychosis and depression(Martinowich et al., 2009).Patient in given scenario is
positive with CYP2D6*10 allele. The CYP2D6 allele plays a vital role in the metabolism if 20
to 30 % of therapeutic important drugs mainly including antipsychotics, antiarrhythmic, tricyclic
antidepressants, beta blockers and opioids(Zheng et al., 2017). The genetic polymorphisms in
CYP2D6 cause the tremendous variation in CYP2D6 enzymes activities(Zheng et al., 2017). The
purpose of paper is to explain the three treatment decision points, factors that might impact the
3
pharmacokinetics and pharmacodynamics processes and explanation of specific patient factors
that may impact decisions(Zheng et al., 2017).
Decision 1
The decision one is to start the patient on Lithium 300 mg orally BID.
The Reason of selection of Selected Treatment option
The reason to select risperidone 1 mg BID Because the patient is already non-compliant
with lithium medication. The patient is complaining of nausea, vomiting, and diarrhea after
taking lithium medication. The patient doe
[Show More]